Multicenter ACL Revision Study (MARS)

Sponsor
Vanderbilt University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT00625885
Collaborator
Vanderbilt University Medical Center (Other), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (NIH)
1,234
49
214
25.2
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to determine the effects of modifiable risk factors on patient-reported quality of life, physical activity levels, and risk of early osteoarthritis following revision anterior cruciate ligament (ACL) reconstruction.

The investigators hypothesize that modifiable variables exist at the time of revision ACL reconstruction (e.g., cause of failure, current graft source and type, surgical exposure, and femoral and tibial tunnel position) which will be predictors of patient-reported outcomes.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Injury to the anterior cruciate ligament (ACL) results in a threat to an active lifestyle and exposes the patient to risk of osteoarthritis. ACL reconstruction is typically chosen by individuals to allow a return to their previous work and sports activities. The results of primary ACL reconstruction have in general been good at restoring functional stability. Primary ACL reconstruction has a graft failure rate ranging from approximately 2%-8%. Consensus amongst surgeons and low-level evidence (retrospective case series) indicate a worse outcome following revision ACL reconstruction compared to primary reconstruction. The typical surgeon performs less than 10 revision ACL reconstructions per year. Thus, the ability of any single surgeon or small group of surgeons to accumulate enough cases to effectively analyze predictors for worse outcome is impossible.

    With this in mind, the Multi-Center ACL Revision Study (MARS) group was established as a multi-center surgeon group to perform a prospective longitudinal cohort analysis of revision ACL reconstruction. This is a mixed group of academic and private practice physicians and has been supported and endorsed by the American Orthopedic Society for Sports Medicine (AOSSM).

    This study focuses on the predictors for ACL revision outcome at 2, 6, and 10 years following a patient's revision ACL reconstruction. This will be accomplished by three Specific Aims. Specific Aim 1 will determine the independent predictors of patient-reported quality of life, utilizing a general (SF-36) and knee-specific (Knee Injury and Osteoarthritis Outcome Score - KOOS) validated outcome instrument. Specific Aim 2 will determine the independent predictors of sports function utilizing three validated outcome instruments (the Marx activity level, International Knee Documentation Committee Subjective form - IKDC, and the KOOS sports and recreation subscale). Specific Aim 3 will identify those independent modifiable predictors measured at the time of the revision ACL reconstruction associated with symptoms of early osteoarthritis at 2, 6, and 10 years post-surgery. Symptoms will be quantified using the validated survey instrument the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Once the predictors for these worse outcomes are identified, surgeons can be educated in potential modifiable variables to improve the outcome.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1234 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Multicenter ACL Revision Study (MARS)
    Study Start Date :
    Feb 1, 2007
    Anticipated Primary Completion Date :
    Dec 1, 2023
    Anticipated Study Completion Date :
    Dec 1, 2024

    Outcome Measures

    Primary Outcome Measures

    1. Graft re-rupture [2, 6, and 10 years after revision ACL surgery]

    Secondary Outcome Measures

    1. Patient based outcome measures [2, 6, and 10 years after revision ACL surgery]

      Activity level (as measured by the Marx activity scale). Sports function (as measured by the KOOS and IKDC). Pain and swelling (as measured by the WOMAC).

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    12 Years to 65 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • All ACL-deficient candidates presenting to the clinic, between the ages of 12† and 65, scheduled to have a revision ACL reconstruction by a participating (MARS Study) surgeon.

    • All participants must have undergone a primary ACL reconstruction in the past and are currently identified as having experienced failure of their primary ACL reconstruction, as defined by either MRI, knee laxity (KT > 5mm), a positive pivot shift or Lachman's, functional instability, and/or by arthroscopic confirmation.

    • All ACL-deficient patients seeking a revision ACL reconstruction that have either partial (Grade I or II) and/or complete (Grade III) simultaneous ligamentous injuries to the collateral ligaments (MCL or LCL) and/or the posterior cruciate ligament (PCL) will also be included.

    • Non-operative treatment of patients with ACLR failure are also eligible to participate.

    • The following graft types will be the only ones accepted for inclusion:

    • any autograft

    • Fresh-frozen allografts from a single donor source (Musculoskeletal Transplant

    Foundation (MTF); Edison, NJ). These grafts should consist of either:
    • bone-patellar tendon-bone

    • tibialis anterior/posterior

    • achilles tendon

    Exclusion Criteria:
    • Patients presenting with prior infection, arthrofibrosis, or regional pain syndrome.

    • Subjects will be excluded if their allograft source does not come from MTF.

    • Patients unwilling or unable to complete their repeat questionnaire two years after their initial visit.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Scripps Memorial Hospital (OrthoCal Healthcare) La Jolla California United States 92123
    2 University of California - Los Angeles (UCLA) Los Angeles California United States 90095
    3 University of California - San Francisco San Francisco California United States 94143
    4 Orthopaedic Associates of Aspen and Glenwood Aspen Colorado United States 81611
    5 University of Colorado Boulder Colorado United States 80304
    6 Connecticut Children's Medical Center Farmington Connecticut United States 06032
    7 University of Connecticut Health Center Farmington Connecticut United States 06034
    8 UHZ Sports Medicine Institute Coral Gables Florida United States 33146
    9 Intermountain Orthopaedics Boise Idaho United States 83703
    10 Rush University Medical Center Chicago Illinois United States 60612
    11 Methodist Sports Medicine Center Indianapolis Indiana United States 46280
    12 University of Iowa Iowa City Iowa United States 52242
    13 Cheaspeake Orthopaedics and Sports Medicine Center Glen Burnie Maryland United States 21061
    14 Beth Israel Deaconess Medical Center Boston Massachusetts United States 02215
    15 University of Michigan Ann Arbor Michigan United States 48106
    16 Mayo Clinic Rochester Minnesota United States 55905
    17 Regions Hospital (Health Partners Research Foundation) Saint Paul Minnesota United States 55101
    18 Washington University at St. Louis Saint Louis Missouri United States 63141
    19 Bridger Orthopaedic and Sports Medicine Bozeman Montana United States 59715
    20 New Hamphsire Knee Center Holderness New Hampshire United States 03217
    21 Robert Wood Johnson Medical School New Brunswick New Jersey United States 08901
    22 Princeton Orthopaedic Associates Princeton New Jersey United States 08540
    23 University of Buffalo Buffalo New York United States 14214
    24 NYU School of Medicine New York New York United States 10016
    25 Hospital for Special Surgery New York New York United States 10021
    26 Manhattan Orthopaedics, P.C. New York New York United States 10021
    27 Keller Army Community Hospital - USMA West Point New York United States 10996
    28 University of North Carolina Medical Center Chapel Hill North Carolina United States 27599
    29 Perry Orthopaedics and Sports Med (Carolinas Healthcare System) Charlotte North Carolina United States 28211
    30 Duke University Durham North Carolina United States 27710
    31 Cleveland Clinic Cleveland Ohio United States 44195
    32 The Ohio State University Columbus Ohio United States 43221
    33 Slocum Research and Education Foundation Eugene Oregon United States 97401
    34 Orthopaedic and Fracture Clinic Portland Oregon United States 97225
    35 The Rothman Institute / Thomas Jefferson University Philadelphia Pennsylvania United States 19085
    36 University of Pennsylvania Philadelphia Pennsylvania United States 19104
    37 Booth, Bartolozzi, Balderston Orthopaedics Philadelphia Pennsylvania United States 19107
    38 Orthopaedic Institute Sioux Falls South Dakota United States 57115
    39 Southeastern Orthopaedics / Knoxville Orthopaedic Clinic Knoxville Tennessee United States 37909
    40 Vanderbilt University Nashville Tennessee United States 37232
    41 W.B. Carroll Memorial Clinic Dallas Texas United States 75204
    42 San Antonio Orthopaedic Group San Antonio Texas United States 78216
    43 University of Vermont College of Medicine Burlington Vermont United States 05405
    44 National Sports Medicine Institute Lansdowne Town Center Virginia United States 20176
    45 Town Center Orthopaedic Associates Reston Virginia United States 20190
    46 Commonwealth Orthopaedics and Rehabilitation Vienna Virginia United States 22181
    47 Inland Orthopaedics/Washington State University Pullman Washington United States 99163
    48 Royal Columbian Hospital (FraserHealth) New Westminster British Columbia Canada V3L3W7
    49 Fowler Kennedy Sports Medicine Clinic/Univ. of Western Ontario London Ontario Canada

    Sponsors and Collaborators

    • Vanderbilt University
    • Vanderbilt University Medical Center
    • National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

    Investigators

    • Principal Investigator: Rick W. Wright, M.D., Vanderbilt University Medical Center
    • Principal Investigator: Kurt P. Spindler, M.D., Vanderbilt University Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kurt P. Spindler, Adjoint Professor, Vanderbilt University
    ClinicalTrials.gov Identifier:
    NCT00625885
    Other Study ID Numbers:
    • 070110
    • R01AR060846
    First Posted:
    Feb 28, 2008
    Last Update Posted:
    Jan 10, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Keywords provided by Kurt P. Spindler, Adjoint Professor, Vanderbilt University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 10, 2022